| Literature DB >> 27052432 |
Yanli Zhao1, Wenbo Luo2, Jingxu Chen1, Dandan Zhang3, Ligang Zhang1, Chunling Xiao1, Fengmei Fan1, Xiaolin Zhu1, Hongzhen Fan1, Shuping Tan1.
Abstract
Self-referential processing is a core component of social cognition. However, few studies have focused on whether self-referential processing deficits present in bipolar disorder. The current study combined a high-time-resolution event-related potential (ERP) technique with the self-referential memory (SRM) task to evaluate self-referential processing in 23 bipolar patients and 27 healthy controls. All subjects showed a reliable SRM effect, but the bipolar group had poorer recognition scores for the self- and other-referential conditions. The bipolar group presented with smaller voltages in both the self- and other-referential conditions for the N1 (150-220 ms) and the P2 components (130-320 ms) but larger voltages in the positive slow wave (600-1600 ms) component. Larger P3 amplitudes were elicited in the self-referential condition compared with the other-referential condition in controls but not in bipolar patients. Additionally, non-psychotic bipolar patients had a comparative normal SRM effect which was abolished in psychotic bipolar patients; non-psychotic bipolar patients had larger amplitudes of the positive slow wave than the normal controls, whereas it was not differed between psychotic bipolar patients and the healthy subjects. The present study suggests that self- and other-referential processing is impaired in bipolar patients and the deficits may be more pronounced in psychotic bipolar patients.Entities:
Mesh:
Year: 2016 PMID: 27052432 PMCID: PMC4823703 DOI: 10.1038/srep24075
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Behavioral results.
(a) Recognition scores of bipolar patients and healthy controlsin the three experimental conditions. (b) Self-referential memory bias scores ofpatients and controls. Error bars correspond to two standard deviations of the mean.
Figure 2Comparisons of grand averaged waveforms between patients with bipolar disorder and healthy controls.
(a) TheN1component at electrode site P7. (b) The P2 component at electrode site F5. (c) The positive slow waveform at electrode site F6.
Figure 3Comparisons of grand averaged waveforms between the self/other-referential and font-judgment conditions within groups.
(a) The N1 component at electrode site P7. (b) The N2 component at electrode site F4. (c) The P3 component at electrode site P2. (d) The positive slow wave component at electrode site F6.
Figure 4Behavioral results forbipolar disordersubtype and healthy control subjects.
(a) Recognition scores in the three experimental conditions. (b) The self-referential memory (SRM) bias scores. Error bars correspond to two standard deviations of the mean.
Figure 5Comparisons of grand averaged waveforms acrosspsychotic, non-psychotic, and healthy control subjects.
(a) The P2 component at electrode site F5. (b) The positive slow waveform at electrode site Fp2.
Demographic and clinical data for patient and control groups.
| Group; mean ± SD or no. (%) | Comparison; P value | ||
|---|---|---|---|
| characteristic | Patients (n = 23) | Controls (n = 27) | Patients v.controls |
| Age (years) | 34.3 ± 12.0 | 32.3 ± 8.64 | 0.497 |
| Education time (years) | 12.6 ± 3.22 | 13.9 ± 2.50 | 0.110 |
| Gender (female) | 11(48) | 14(52) | 0.777 |
| Handeness (right) | 23(100) | 27(100) | |
| Age at onset (years) | 23.8 ± 8.30 | ||
| Days of hospital stay | 14(17) | ||
| Duration of illness (years) | 10.5 ± 9.05 | ||
| Current symptomatoloty | |||
| CGI-S | 5.13 ± 1.25 | ||
| Depression (HAMD) | 6.2 ± 8.61 | ||
| Mania (YMRS) | 18.2 ± 10.53 | ||
| Medication | |||
| valproate | 15(65) | ||
| antidepressants | 5(22) | ||
| antipsychotics | 22(96) | ||
| lithium | 3(13) | ||
| Psychotic bipolar patients (n = 9) | Non-psychotic bipolar patients (n = 14) | Psychotic patients vs. non-psychotic patients | |
| Age (years) | 37.7 ± 11.0 | 32.1 ± 12.5 | 0.285 |
| Gender (male/female) | 3/6 | 9/5 | 0.214 |
| Education time (years) | 12.2 ± 2.9 | 12.9 ± 3.5 | 0.655 |
| Days of hospital stay | 19.6 ± 12.0 | 20.9 ± 22.1 | 0.866 |
| Illness duration (years) | 9.44 ± 4.16 | 4.50(16.75) | 0.776 |
| CGI-S | 5.11 ± 1.05 | 5.14 ± 1.41 | 0.954 |
| HAMD | 3.93 ± 3.55 | 2.50(16) | 0.949 |
| YMRS | 20.96 ± 9.35 | 16.37 ± 11.18 | 0.319 |
| Medication dosage | |||
| valproate | 500(500) | 500(500) | 0.572 |
| antipsychotics | 250(175) | 423.89 ± 293.65 | 0.227 |
*Unless indicated otherwise.
†Median (interquartile range) and significance was determined with the nonparametric Mann–Whitney U test.